Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis
J.P. Clancy Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis Am. J. Respir. Crit. Care Med. 163 2001 1683 1692
High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening
T. Ma High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening J. Biol. Chem. 277 2002 37235 37241
Evidence against rescue of defective Δf508-CFTR cellular processing by curcumin in cell culture and mouse models
Y. Song Evidence against rescue of defective ΔF508-CFTR cellular processing by curcumin in cell culture and mouse models J. Biol. Chem. 2004 10.1074/jbc.M407308200 (http://www.jbc.org/)
A Δf508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo
P.J. French A ΔF508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo J. Clin. Invest. 98 1996 1304 1312
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa
A. van Heeckeren Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa J. Clin. Invest. 100 1997 2810 2815